CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-28 | VESSEY RUPERT Director | Grant or award | +194 | 1,227 | ||
| 2021-10-28 | VESSEY RUPERT Director | Grant or award · Stock Option (right to buy) | +633 | 633 | ||
| 2021-10-28 | Seth Alpna Director | Grant or award | +194 | 2,333 | ||
| 2021-10-28 | Seth Alpna Director | Grant or award · Stock Option (right to buy) | +633 | 633 | ||
| 2021-10-28 | Hippel James Chief Financial Officer | Sale | −100 | $525.18 | $53K | 10,755 |
| 2021-10-28 | Bushman Julie L Director | Grant or award | +194 | 674 | ||
| 2021-10-28 | Bushman Julie L Director | Grant or award · Stock Option (right to buy) | +633 | 633 | ||
| 2021-10-26 | Furlow Brenda S. SVP - General Counsel | Gift | −1,330 | 6,290 | ||
| 2021-10-26 | Furlow Brenda S. SVP - General Counsel | Gift | +1,330 | 1,330 | ||
| 2021-10-26 | Furlow Brenda S. SVP - General Counsel | Gift | −1,330 | 4,960 | ||
| 2021-10-26 | Furlow Brenda S. SVP - General Counsel | Gift | +1,330 | 1,330 | ||
| 2021-09-22 | Kelderman Kim Pres. Diagnostics & Genom | Sale | −822 | $529.04 | $435K | 0 |
| 2021-09-07 | STEER RANDOLPH C Director | Option exercise | +4,000 | $87.39 | $350K | 9,112 |
| 2021-09-07 | STEER RANDOLPH C Director | Option exercise | +4,000 | $91.78 | $367K | 13,112 |
| 2021-09-07 | STEER RANDOLPH C Director | Sale | −2,900 | $509.33 | $1.5M | 10,212 |
| 2021-09-07 | STEER RANDOLPH C Director | Sale | −4,600 | $510.23 | $2.3M | 5,612 |
| 2021-09-07 | STEER RANDOLPH C Director | Sale | −500 | $511.45 | $256K | 5,112 |
| 2021-09-07 | STEER RANDOLPH C Director | Option exercise · Stock Option (right to buy) | −4,000 | 0 | ||
| 2021-09-07 | STEER RANDOLPH C Director | Option exercise · Stock Option (right to buy) | −4,000 | 0 | ||
| 2021-09-02 | Kummeth Charles R. Chief Executive Officer | Option exercise | +73,492 | $108.49 | $8.0M | 238,606 |
Page 28 of 32 · 626 trades